INTERNATIONAL PATENT: INNOVENT BIOLOGICS (SUZHOU) CO., LTD., 信达生物制药（苏州）有限公司 FILES APPLICATION FOR "PHARMACEUTICAL COMBINATION CONTAINING ANTI-IGF-1R AND ANTI-CD40L ANTIBODIES AND USE THEREOF AND METHOD FOR USING SAME"

GENEVA, May 9 -- INNOVENT BIOLOGICS (SUZHOU) CO., LTD. (168 Dongping Street, Suzhou Industrial ParkSuzhou, Jiangsu 215123), 信达生物制药（苏州）有限公司 (中国江苏省苏州市苏州工业园区东平街168号) filed a patent application (PCT/CN2025/130245) for "PHARMACEUTICAL COMBINATION CONTAINING ANTI-IGF-1R AND ANTI-CD40L ANTIBODIES, AND USE THEREOF AND METHOD FOR USING SAME" on Oct 27, 2025. With publication no. WO/2026/092387, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the Int...